Managing atherogenic dyslipidaemia QI program
You need to login to participate in this QI program.
This education is accredited: RACGP 40 CPD, ACRRM 30 CME PD.
QI Program Aim
While cardiovascular disease is widely understood to be one of Australia's largest health issues, atherogenic dyslipidaemia - a lipid abnormality associated with increased CVD risk - is currently under-managed in general practice. This QI (Quality Improvement) Program aims to optimise pharmacological and non-pharmacological management of lipid abnormalities in patients with atherogenic dyslipidaemia, to achieve a reduction in cardiovascular disease risk in patients.
The Managing Atherogenic Dyslipidaemia (MAD) QI Program has been designed using the latest guidelines to assist GPs in reviewing and prescribing optimal lipid management strategies in 7 patients with atherogenic dyslipidaemia, concluding with a reflective activity where they can review their management skills and strategies.
- Patients with type 2 diabetes
- Currently taking a statin
- Measured to have atherogenic dyslipidaemia (HDL-C levels < 1 mmol/L and Triglycerides > 2 mmol/L) within the last 12 months
- The QI program has been designed to take approximately 8-10 weeks to complete. This includes patient recall from your practice, patient consult and program evaluation.
What the GP needs to do
- Log in or register to ThinkGP
- Use the 'Click here to proceed' button to get started.
- Read the background information on the QI program's underlying evidence and best practice statements and answer some questions.
- It would be a good idea to complete this 10 minute activity before your first patient.
Tips to identify patients
Perform a search on your practice software using the following search criteria: (Please consult your practice software help or support function if required).
- Diagnosis: Type 2 diabetes
- Medications: Statins
- Lipid levels: HDL-C levels < 0.88 mmol/L and Triglycerides > 2.3 mmol/L
Recall these patients for a consultation - click here to download a recall letter that can be mail merged using your practice software or handed out by your practice nurse.
- Diet and lifestyle self-management
- Additional causes of elevated triglycerides
- Drugs that increase risk of hyperlipidaemia
- Residual CVD risk
- Additional therapy
- Risk of diabetic retinopathy
Enter this information in the patient data entry section of the QI program.
- Discuss a management plan with the patient based on current evidence and considered best practice
- Suggestions for a management plan will be automatically generated based on the data you enter in the patient entry form.
- Once you have entered data for 7 patients, review your results, evaluate the QI program process and reflect upon whether you have made any changes to your clinical practice based on this activity.
- Completion of this activity will award you 40 RACGP QI&CPD points, or 30 ACRRM PDP points.
- If a nurse assisted you in completing the QI program and wants to claim CPD points download a certificate here.
This program is supported by Mylan Australia.
|Managing Atherogenic Dyslipidaemia QI Program - Pre-test|
|Managing Atherogenic Dyslipidaemia QI Program - Declaration|
|Managing Atherogenic Dyslipidaemia QI Program - Patient Entry|
|Managing Atherogenic Dyslipidaemia QI Program - Results and Evaluation|